Anti-inflammatory mechanism of Apolipoprotein A-I

被引:4
|
作者
Tao, Xia [1 ]
Tao, Ran [1 ]
Wang, Kaiyang [1 ]
Wu, Lidong [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Jiangxi Med Coll, Dept Emergency, Nanchang, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
Apolipoprotein A-I; macrophage; dendritic cell; neutrophil; T lymphocyte; anti-inflammatory; HIGH-DENSITY-LIPOPROTEIN; SYNTHETIC PEPTIDE ANALOGS; ACUTE LUNG INJURY; APOA-I; HUMAN MONOCYTES; MYOCARDIAL-INFARCTION; AMPHIPATHIC HELIX; INFLAMMATION; CHOLESTEROL; CELL;
D O I
10.3389/fimmu.2024.1417270
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Apolipoprotein A-I(ApoA-I) is a member of blood apolipoproteins, it is the main component of High density lipoprotein(HDL). ApoA-I undergoes a series of complex processes from its generation to its composition as spherical HDL. It not only has a cholesterol reversal transport function, but also has a function in modulating the inflammatory response. ApoA-I exerts its anti-inflammatory effects mainly by regulating the functions of immune cells, such as monocytes/macrophages, dendritic cells, neutrophils, and T lymphocytes. It also modulates the function of vascular endothelial cells and adipocytes. Additionally, ApoA-I directly exerts anti-inflammatory effects against pathogenic microorganisms or their products. Intensive research on ApoA-I will hopefully lead to better diagnosis and treatment of inflammatory diseases.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Human Apolipoprotein A-I Mutants
    Francheschini, Guido
    HIGH DENSITY LIPOPROTEINS, DYSLIPIDEMIA, AND CORONARY HEART DISEASE, 2010, : 63 - 69
  • [42] Apolipoprotein A-I mimetic peptides
    Navab, M
    Anantharamaiah, GM
    Reddy, ST
    Hama, S
    Hough, G
    Grijalva, VR
    Yu, N
    Ansell, BJ
    Datta, G
    Garber, DW
    Fogelman, AM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (07) : 1325 - 1331
  • [43] Apolipoprotein A-I induced amyloidosis
    Genschel, J
    Haas, R
    Pröpsting, MJ
    Schmidt, HHJ
    FEBS LETTERS, 1998, 430 (03): : 145 - 149
  • [44] Apolipoprotein A-I Mimetic Peptides
    Van Lenten, Brian J.
    Wagner, Alan C.
    Anantharamaiah, G. M.
    Navab, Mohamad
    Reddy, Srinivasa T.
    Buga, Georgette M.
    Fogelman, Alan M.
    CURRENT ATHEROSCLEROSIS REPORTS, 2009, 11 (01) : 52 - 57
  • [45] ASPECIFICITY OF APOLIPOPROTEIN A-I ANTISERA
    COBBAERT, C
    BERTELS, I
    STAELS, B
    VERHOEVEN, G
    LISSENS, W
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1988, 26 (05): : 291 - 291
  • [46] IMMUNOLOGICAL ESTIMATION OF APOLIPOPROTEIN A-I
    AYRAULTJARRIER, M
    BOBILEWICZ, D
    PASTIER, D
    BEUCLER, I
    POLONOVSKI, J
    ANNALES DE BIOLOGIE CLINIQUE, 1982, 40 (03) : 187 - 194
  • [47] Human Apolipoprotein A-I Deficiency
    Schaefer, Ernst J.
    Santos, Raul D.
    HIGH DENSITY LIPOPROTEINS, DYSLIPIDEMIA, AND CORONARY HEART DISEASE, 2010, : 55 - +
  • [48] The promise of apolipoprotein A-I mimetics
    Mendez, Armando J.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2010, 17 (02) : 171 - 176
  • [49] Apolipoprotein A-I is a molecular lariat
    Segrest, JP
    Harvey, S
    Jones, MK
    CIRCULATION, 1998, 98 (17) : 2 - 2
  • [50] PHOSPHORYLATION OF HUMAN APOLIPOPROTEIN A-I
    BEG, ZH
    STONIK, JA
    HOEG, JM
    DEMOSKY, SJ
    BREWER, HB
    CIRCULATION, 1987, 76 (04) : 117 - 117